文献速递类风湿关节炎

小鼠T细胞缺失MALT1可预防自身免疫性关节炎但导致自发性骨质疏松

Deletion of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 in Mouse T Cells Protects Against Development of Autoimmune Arthritis but Leads to Spontaneous Osteoporosis.
PubMed 文献 · Arthritis Rheumatol · 2019-11-09

该研究在胶原诱导性关节炎(CIA)和胶原抗体诱导性关节炎(CAIA)小鼠模型中探讨MALT1的作用。T细胞特异性MALT1缺失在关节炎诱导期完全保护小鼠免于CIA(发生率对照组25% vs Malt1iTcell KO小鼠0%,P<0.05),但对效应期无影响;MALT1缺陷小鼠出现骨密度自发下降(骨小梁厚度均值±SEM:对照组46.3±0.7 μm vs Malt1KO小鼠40±1.1 μm,P<0.001),与Treg细胞减少相关。

要点

  • T细胞特异性MALT1缺失在诱导期完全预防CIA,但对CAIA无效。
  • MALT1缺陷导致自发性骨密度下降,与Treg细胞减少相关。
  • MALT1是T细胞活化的关键调控因子,但靶向治疗需警惕骨质疏松风险。

核心结论

  • MALT1是T细胞活化的关键调控因子,参与自身免疫性关节炎发病,但MALT1缺陷可导致自发性骨质疏松并与Treg细胞数量减少相关。

研究设计与样本

  • 研究采用CIA和CAIA小鼠模型,通过检测CYLD切割评估MALT1活化。
  • 使用Malt1KO小鼠、T细胞特异性MALT1缺失小鼠(Malt1Tcell KO)和他莫昔芬诱导型T细胞特异性MALT1缺失小鼠(Malt1iTcell KO)评估关节炎和骨密度。
  • 通过micro-CT和股骨弯曲试验测定骨密度,并通过过继转移实验重建Treg细胞。

主要发现

  • CIA小鼠淋巴细胞中观察到MALT1活化。
  • T细胞特异性MALT1缺失在关节炎诱导期完全保护小鼠免于CIA(发生率:对照组25% vs Malt1iTcell KO小鼠0%,P<0.05),但在效应期无保护作用。
  • MALT1缺陷对CAIA(RA效应期模型)无影响。
  • MALT1缺陷小鼠骨密度自发下降(骨小梁厚度均值±SEM:对照组46.3±0.7 μm vs Malt1KO小鼠40±1.1 μm,P<0.001),与Treg细胞丢失相关。

关键数值与推荐

  • CIA发生率:对照组25% vs Malt1iTcell KO小鼠0%,P<0.05(诱导期T细胞特异性MALT1缺失)。
  • 骨小梁厚度均值±SEM:对照组46.3±0.7 μm vs Malt1KO小鼠40±1.1 μm,P<0.001。

临床怎么用

  • MALT1作为RA治疗靶点需权衡关节炎保护作用与骨质疏松风险。
  • 靶向MALT1时需监测骨密度和Treg细胞数量变化。

局限性

  • 研究仅基于小鼠模型,结论需在人体中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT-1) plays a crucial role in innate and adaptive immune signaling by modulating the threshold for activation of immune cells, including Treg cells. Therefore, MALT-1 is regarded to be an interesting therapeutic target in several immune-mediated diseases. The goal of this study was to examine the role of MALT-1 in experimental animal models of rheumatoid arthritis (RA). METHODS: MALT-1 activation was assessed by measuring cleavage of the deubiquitinase CYLD in lymphocytes from mice with collagen-induced arthritis (CIA). Furthermore, the impact of MALT-1 deficiency on arthritis was evaluated in Malt1KO mice with CIA or with collagen antibody-induced arthritis (CAIA). T cell-specific MALT-1 deficiency was measured in mice with deletion of T cell-specific MALT-1 (Malt1Tcell KO ), and the time-dependent effects of MALT-1 deficiency were assessed in mice with deletion of tamoxifen-inducible T cell-specific MALT-1 (Malt1iTcell KO ). Bone density was determined in MALT-1-deficient mice using micro-computed tomography and femur-bending tests. Reconstitution of Treg cells was performed using adoptive transfer experiments. RESULTS: MALT-1 activation was observed in the lymphocytes of mice with CIA. T cell-specific MALT-1 deletion in the induction phase of arthritis (incidence of arthritis, 25% in control mice versus 0% in Malt1iTcell KO mice; P < 0.05), but not in the effector phase of arthritis, completely protected mice against the development of CIA. Consistent with this finding, MALT-1 deficiency had no impact on CAIA, an effector phase model of RA. Finally, mice with MALT-1 deficiency showed a spontaneous decrease in bone density (mean ± SEM trabecular thickness, 46.3 ± 0.7 μm in control mice versus 40 ± 1.1 μm in Malt1KO mice; P < 0.001), which was linked to the loss of Treg cells in these mice. CONCLUSION: Overall, these data in murine models of RA highlight MALT-1 as a master regulator of T cell activation, which is relevant to the pathogenesis of autoimmune arthritis. Furthermore, these findings show that MALT-1 deficiency can lead to spontaneous osteoporosis, which is associated with impaired Treg cell numbers.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Gilis E, Gaublomme D, Staal J, et al. Deletion of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 in Mouse T Cells Protects Against Development of Autoimmune Arthritis but Leads to Spontaneous Osteoporosis. Arthritis Rheumatol. 2019. PMID: 31259485. doi:10.1002/art.41029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。